# US 2025/0144071 A1 · Method for producing ellagic acid-containing composition and ellagic acid-containing composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144071 A1
- Document ID: US20250144071A1
- Status: Published application
- Kind: A1
- Application number: 18/838,164
- Filed: 2023-03-24
- Published: 2025-05-08
- Earliest claimed: 2022-03-28
- Assignees: Sumitomo Chemical Company, Limited
- Applicants: Sumitomo Chemical Company, Limited
- Inventors: Toshihiro YONEYAMA; Masanori KUSUMOTO; Mikio AOKI; Kazuki MIKATA
- Web page: https://patentgrep.com/patent/US20250144071A1

## CPC

- A61K 8/498: {having 6-membered rings or their condensed derivatives, e.g. coumarin}
- A61K 31/37: Coumarins, e.g. psoralen
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 17/00: Drugs for dermatological disorders
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 35/00: Antineoplastic agents
- A61P 39/06: Free radical scavengers or antioxidants
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/10: Washing or bathing preparations
- A61K 2236/30: Extraction of the material
- A61K 2236/33: involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K 2236/37: Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

An object of the present disclosure is to provide a novel method for producing an ellagic acid-containing composition, the method capable of improving the solubility of ellagic acid. The present embodiment is a method for producing an ellagic acid-containing composition, including: a step of providing a solution containing at least an aqueous medium and a raw material derived from a plant of the genus Terminalia, containing ellagic acid; and a step of heat-treating the solution. The present embodiment is the production method, further including a step of a hydrolysis treatment to hydrolyze ellagitannin contained in the raw material to produce additional ellagic acid, wherein the hydrolysis-treated solution is heat-treated.

## Claims

### Claim 1

A method for producing an ellagic acid-containing composition, the method comprising:
providing a solution comprising at least an aqueous medium and a raw material derived from a plant of the genus Terminalia, comprising ellagic acid; and
heat-treating the solution.

### Claim 2 (depends on 1)

The method according to claim 1, further comprising a hydrolysis treatment to hydrolyze ellagitannin contained in the raw material to produce additional ellagic acid, wherein the hydrolysis-treated solution is heat-treated.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the hydrolysis treatment is hydrolysis with an acid.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the solution further comprises ellagic acid added separately from ellagic acid contained in the raw material derived from a plant of the genus Terminalia.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the plant of the genus Terminalia is Terminalia catappa.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the raw material derived from a plant of the genus Terminalia is at least one material selected from the group consisting of leaves, fruits, stems, and branches of a plant of the genus Terminalia, or is an extract extracted from at least one material selected from the group consisting of leaves, fruits, stems, and branches of a plant of the genus Terminalia with an extraction medium.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the raw material derived from a plant of the genus Terminalia is an extract extracted from at least one material selected from the group consisting of leaves, fruits, stems, and branches of a plant of the genus Terminalia with an extraction medium.

### Claim 8 (depends on 6)

The method according to claim 6, wherein the extraction medium is water, an aqueous medium, or a mixture thereof.

### Claim 9 (depends on 6)

The method according to claim 6, wherein the extraction medium is water, an alcohol, or a mixture thereof.

### Claim 10 (depends on 1)

The method according to claim 1, wherein a temperature for the heat treatment is at least 60° C. or more.

### Claim 11 (depends on 1)

The method according to claim 1, wherein a temperature for the heat treatment is less than 100° C.

### Claim 12

The method according to, wherein the aqueous medium in the solution is water, alcohol, or a mixture thereof.

### Claim 13 (depends on 1)

The method according to claim 1, further comprising concentration-treating a solution after the heat-treating.

### Claim 14 (depends on 1)

The method according to claim 1, wherein a concentration of ellagic acid dissolved in a solution obtained by the heat-treating, or concentration-treating when performing the concentration treatment after the heat-treating is at least 50 μg/mL.

### Claim 15 (depends on 1)

The method according to claim 1, further comprising dry-treating the solution, after the heat-treating, or after concentration-treating when performing the concentration treatment after the heat-treating, to obtain an ellagic acid-containing solid.

### Claim 16 (depends on 1)

An ellagic acid-containing composition obtained by the method according to claim 1.

### Claim 17 (depends on 16)

A medicine, cosmetic, quasi-drug, or food or drink comprising the ellagic acid-containing composition according to claim 16.

### Claim 18

(canceled)
